RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.

Nature
Georgia HatzivassiliouShiva Malek

Abstract

Activating mutations in KRAS and BRAF are found in more than 30% of all human tumours and 40% of melanoma, respectively, thus targeting this pathway could have broad therapeutic effects. Small molecule ATP-competitive RAF kinase inhibitors have potent antitumour effects on mutant BRAF(V600E) tumours but, in contrast to mitogen-activated protein kinase kinase (MEK) inhibitors, are not potent against RAS mutant tumour models, despite RAF functioning as a key effector downstream of RAS and upstream of MEK. Here we show that ATP-competitive RAF inhibitors have two opposing mechanisms of action depending on the cellular context. In BRAF(V600E) tumours, RAF inhibitors effectively block the mitogen-activated protein kinase (MAPK) signalling pathway and decrease tumour growth. Notably, in KRAS mutant and RAS/RAF wild-type tumours, RAF inhibitors activate the RAF-MEK-ERK pathway in a RAS-dependent manner, thus enhancing tumour growth in some xenograft models. Inhibitor binding activates wild-type RAF isoforms by inducing dimerization, membrane localization and interaction with RAS-GTP. These events occur independently of kinase inhibition and are, instead, linked to direct conformational effects of inhibitors on the RAF kinase domain. O...Continue Reading

References

Dec 1, 1994·Molecular and Cellular Biology·T JelinekM J Weber
Oct 3, 1999·Nature Biotechnology·M V MatzS A Lukyanov
Jun 15, 2000·The Journal of Biological Chemistry·K A LukyanovS A Lukyanov
Sep 24, 2002·The Journal of Biological Chemistry·Xiaoqin XiangZhijun Luo
Oct 8, 2003·The Journal of Biological Chemistry·Christine A GoetzMichael A Farrar
Mar 18, 2004·Cancer Research·Jung-Sik KimTodd Waldman
Mar 24, 2004·Cell·Paul T C WanUNKNOWN Cancer Genome Project
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
Nov 3, 2004·Nature Reviews. Molecular Cell Biology·Claudia WellbrockRichard Marais
Mar 2, 2006·Molecular and Cellular Biology·Linda K RushworthWalter Kolch
Mar 27, 2007·Nature Reviews. Cancer·Suzanne SchubbertGideon Bollag
Nov 21, 2007·Expert Opinion on Therapeutic Targets·Vladimir KhazakErica A Golemis
Feb 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·James TsaiGideon Bollag
Aug 5, 2008·Bioorganic & Medicinal Chemistry Letters·Joshua D HansenAlan Olivero
Sep 9, 2008·The Journal of Biological Chemistry·Mengwei ZangZhijun Luo
May 26, 2009·Nature Structural & Molecular Biology·Angus J M CameronPeter J Parker
May 26, 2009·Nature Chemical Biology·Tatsuya OkuzumiKevan M Shokat
Sep 1, 2009·Nature Chemical Biology·Valerie HindieRicardo M Biondi
Sep 4, 2009·Nature·Thanashan RajakulendranMarc Therrien

❮ Previous
Next ❯

Citations

Aug 25, 2011·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·C Hafner
Jun 27, 2012·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·A S Yazdi
Jul 26, 2012·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Keitaro YamaneHironobu Ihn
Mar 3, 2012·Cancer Immunology, Immunotherapy : CII·Vafa ShahabiJeffrey R Jackson
Jul 5, 2013·Journal of Cancer Research and Clinical Oncology·Daniel ChanH Phillip Koeffler
Apr 6, 2012·Annals of Biomedical Engineering·Sameer S Bajikar, Kevin A Janes
Aug 22, 2013·Breast Cancer Research and Treatment·Claudia FumarolaMara A Bonelli
Feb 20, 2013·Current Treatment Options in Oncology·Douglas B Johnson, Jeffrey A Sosman
Oct 15, 2011·Current Oncology Reports·Moriah H Nissan, David B Solit
Mar 7, 2013·Current Oncology Reports·Viswanath Reddy BelumMario E Lacouture
Oct 17, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·S Martín-AlgarraUNKNOWN Spanish Society of Medical Oncology
May 4, 2012·Archives of Pharmacal Research·Do-Hee Kim, Taebo Sim
May 8, 2013·Drugs·Charlotte LemechHendrik-Tobias Arkenau
Jan 2, 2013·Biochimica Et Biophysica Acta·Allan Joaquim LamontanaraOliver Hantschel
Dec 10, 2013·Blood Cells, Molecules & Diseases·Emily K SchaefferChristopher H Lowrey
Dec 3, 2013·Biochemical Pharmacology·Amanda D Bucheit, Michael A Davies
Feb 25, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Mohammad KrayemGhanem Ghanem
Aug 21, 2013·Trends in Molecular Medicine·Ruth NussinovCarla Mattos
Dec 12, 2013·Pharmacology & Therapeutics·Carolina Hertzman Johansson, Suzanne Egyhazi Brage
Nov 3, 2011·Expert Reviews in Molecular Medicine·Ivan PachecoVictor Tron
Jul 20, 2012·Journal of Medicinal Chemistry·Xiaolun Wang, Joseph Kim
Feb 13, 2013·Journal of Medicinal Chemistry·Melissa M VasbinderMinwei Ye
Dec 7, 2011·Cell Research·Jihan K OsborneMelanie H Cobb
Apr 16, 2011·Leukemia·L S SteelmanJ A McCubrey
Jul 9, 2010·Nature·Jonathan A HollanderPaul J Kenny
Nov 26, 2010·Nature·Cory M JohannessenLevi A Garraway
Feb 22, 2011·Nature Cell Biology·Yuji KubotaMutsuhiro Takekawa
Nov 13, 2012·Nature Chemical Biology·Ratika KrishnamurtyDustin J Maly
Nov 15, 2011·Nature Medicine·Ainhoa MielgoDavid A Cheresh
Nov 10, 2013·Nature Medicine·Piro LitoDavid B Solit
Mar 9, 2011·Nature Medicine·Alison Farrell
Mar 9, 2011·Nature Medicine·Julian Downward
Aug 20, 2010·Nature Reviews. Cancer·Donal J BrennanWilliam M Gallagher
Feb 18, 2011·Nature Reviews. Cancer·Ki Won LeeZigang Dong
Sep 24, 2011·Nature Reviews. Cancer·Nilay Sethi, Yibin Kang
Sep 16, 2011·Nature Reviews. Cancer·Ya CaoKaren Vousden
Apr 6, 2012·Nature Reviews. Cancer·Keith T FlahertyDavid E Fisher
May 25, 2011·Nature Reviews. Clinical Oncology·Antoni Ribas, Keith T Flaherty
Jan 30, 2013·Nature Reviews. Clinical Oncology·Sook Ryun ParkShivaani Kummar
May 29, 2013·Nature Reviews. Clinical Oncology·Geoffrey T GibneyKeiran S M Smalley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.